AEMD: Hemopurifier shows early promise in oncology trials, with strong platform and financial position
Hemopurifier, a blood filtration device, is showing promising early results in oncology trials by reducing harmful particles and supporting immune function. The company is well-financed, focused on completing its current trial, and aims to expand its platform to multiple disease areas.Based on Aeth…